SG11201503441XA - A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker - Google Patents
A pharmaceutical composition containing an ace inhibitor and a calcium channel blockerInfo
- Publication number
- SG11201503441XA SG11201503441XA SG11201503441XA SG11201503441XA SG11201503441XA SG 11201503441X A SG11201503441X A SG 11201503441XA SG 11201503441X A SG11201503441X A SG 11201503441XA SG 11201503441X A SG11201503441X A SG 11201503441XA SG 11201503441X A SG11201503441X A SG 11201503441XA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- composition containing
- calcium channel
- channel blocker
- ace inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL401632A PL227900B1 (en) | 2012-11-15 | 2012-11-15 | Pharmaceutical composition comprising an ACE inhibitor and a calcium channel blocker, a method for its preparation and the dosage unit comprising the composition |
| PCT/IB2013/060069 WO2014076632A1 (en) | 2012-11-15 | 2013-11-12 | A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201503441XA true SG11201503441XA (en) | 2015-05-28 |
Family
ID=49724636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201503441XA SG11201503441XA (en) | 2012-11-15 | 2013-11-12 | A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2919815B1 (en) |
| AU (1) | AU2013346397B2 (en) |
| BR (1) | BR112015010119A2 (en) |
| EA (1) | EA027568B1 (en) |
| ES (1) | ES2650468T3 (en) |
| HK (1) | HK1213807A1 (en) |
| HR (1) | HRP20171863T1 (en) |
| HU (1) | HUE035163T2 (en) |
| MX (1) | MX353689B (en) |
| MY (1) | MY170451A (en) |
| PH (1) | PH12015501036B1 (en) |
| PL (2) | PL227900B1 (en) |
| PT (1) | PT2919815T (en) |
| RS (1) | RS56664B1 (en) |
| SG (1) | SG11201503441XA (en) |
| UA (1) | UA114439C2 (en) |
| WO (1) | WO2014076632A1 (en) |
| ZA (1) | ZA201504265B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3275432A1 (en) * | 2016-07-25 | 2018-01-31 | H e x a l Aktiengesellschaft | Dosage form with ace inhibitor |
| EP4106733A2 (en) * | 2020-02-10 | 2022-12-28 | Adamed Pharma S.A. | Stable ramipril composition and fixed dose composition comprising thereof |
| GB2595203A (en) * | 2020-03-03 | 2021-11-24 | Alkaloid Ad Skopje | Formulation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743450A (en) | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| DE3739690A1 (en) | 1987-11-24 | 1989-06-08 | Hoechst Ag | STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS |
| US5093129A (en) | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
| BR0003282A (en) | 2000-07-14 | 2002-02-26 | Libbs Farmaceutica Ltda | Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure |
| CA2357982A1 (en) | 2001-09-28 | 2003-03-28 | Bernard Charles Sherman | Solid compositions comprising ramipril |
| ATE357933T1 (en) | 2002-01-15 | 2007-04-15 | Actavis Group Hf | FORMULATIONS OF QUINAPRIL AND RELATED ACE INHIBITORS |
| US20030215526A1 (en) | 2002-03-08 | 2003-11-20 | Scott Stofik | Stable formulations of angiotensin converting enzyme (ACE) inhibitors |
| US20050181055A1 (en) | 2003-10-08 | 2005-08-18 | Mathur Rajeev S. | Pharmaceutical compositions of quinapril |
| HUE031058T2 (en) | 2004-03-29 | 2017-06-28 | Servier Lab | Process for preparing a solid pharmaceutical composition |
| HUP0401170A2 (en) * | 2004-06-10 | 2006-09-28 | Richter Gedeon Vegyeszet | Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for |
| EP1863457A2 (en) * | 2005-03-15 | 2007-12-12 | Lupin Ltd. | Pharmaceutical compositions of amlodipine and benazepril. |
| JP2009508948A (en) * | 2005-09-28 | 2009-03-05 | テバ ファーマシューティカル インダストリーズ リミティド | Stable combination of amlodipine besylate and benazepril hydrochloride |
| US20070116762A1 (en) | 2005-11-07 | 2007-05-24 | Wilson Edward S | Compositions of stabilized ramipril in combination with another active agent |
| WO2008065485A2 (en) | 2006-10-19 | 2008-06-05 | Torrent Pharmaceuticals Limited | Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor |
| PL2538924T3 (en) * | 2010-02-24 | 2014-10-31 | Sanofi Aventis Deutschland | Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
-
2012
- 2012-11-15 PL PL401632A patent/PL227900B1/en unknown
-
2013
- 2013-11-12 BR BR112015010119A patent/BR112015010119A2/en active Search and Examination
- 2013-11-12 PT PT138018247T patent/PT2919815T/en unknown
- 2013-11-12 RS RS20171233A patent/RS56664B1/en unknown
- 2013-11-12 EA EA201590529A patent/EA027568B1/en unknown
- 2013-11-12 MX MX2015006122A patent/MX353689B/en active IP Right Grant
- 2013-11-12 SG SG11201503441XA patent/SG11201503441XA/en unknown
- 2013-11-12 AU AU2013346397A patent/AU2013346397B2/en active Active
- 2013-11-12 ES ES13801824.7T patent/ES2650468T3/en active Active
- 2013-11-12 WO PCT/IB2013/060069 patent/WO2014076632A1/en active Application Filing
- 2013-11-12 EP EP13801824.7A patent/EP2919815B1/en active Active
- 2013-11-12 MY MYPI2015001135A patent/MY170451A/en unknown
- 2013-11-12 HU HUE13801824A patent/HUE035163T2/en unknown
- 2013-11-12 UA UAA201505719A patent/UA114439C2/en unknown
- 2013-11-12 PL PL13801824T patent/PL2919815T3/en unknown
-
2015
- 2015-05-08 PH PH12015501036A patent/PH12015501036B1/en unknown
- 2015-06-12 ZA ZA2015/04265A patent/ZA201504265B/en unknown
-
2016
- 2016-02-19 HK HK16101893.8A patent/HK1213807A1/en unknown
-
2017
- 2017-11-29 HR HRP20171863TT patent/HRP20171863T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201590529A1 (en) | 2015-09-30 |
| MY170451A (en) | 2019-07-31 |
| PH12015501036A1 (en) | 2015-08-17 |
| UA114439C2 (en) | 2017-06-12 |
| WO2014076632A1 (en) | 2014-05-22 |
| HK1213807A1 (en) | 2016-07-15 |
| HUE035163T2 (en) | 2018-05-02 |
| PL401632A1 (en) | 2014-05-26 |
| AU2013346397A1 (en) | 2015-06-18 |
| PT2919815T (en) | 2017-12-11 |
| EP2919815B1 (en) | 2017-09-06 |
| PL227900B1 (en) | 2018-01-31 |
| HRP20171863T1 (en) | 2018-01-12 |
| EA027568B1 (en) | 2017-08-31 |
| AU2013346397B2 (en) | 2017-09-14 |
| ZA201504265B (en) | 2017-11-29 |
| MX2015006122A (en) | 2015-08-05 |
| PL2919815T3 (en) | 2018-01-31 |
| RS56664B1 (en) | 2018-03-30 |
| BR112015010119A2 (en) | 2017-07-11 |
| ES2650468T3 (en) | 2018-01-18 |
| EP2919815A1 (en) | 2015-09-23 |
| MX353689B (en) | 2018-01-23 |
| PH12015501036B1 (en) | 2015-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1253692A1 (en) | Pharmaceutical composition comprising an hdac inhibitor and a cyclopolysaccharide | |
| SI2920149T1 (en) | 3-aminocycloalkyl compounds as ror-gamma-t inhibitors and uses thereof | |
| HK1214170A1 (en) | Coated pharmaceutical composition containing regorafenib | |
| EP2568812A4 (en) | Novel prolylcarboxypeptidase inhibitors | |
| IL225434A0 (en) | Pharmaceutical compositions containing a dgat1 inhibitor | |
| SG11201402079QA (en) | Pharmaceutical composition useful for adhesion prevention or hemostasis | |
| EP2571359A4 (en) | Novel prolylcarboxypeptidase inhibitors | |
| EP2579716A4 (en) | Novel prolylcarboxypeptidase inhibitors | |
| EP2571855A4 (en) | Novel prolylcarboxypeptidase inhibitors | |
| HRP20171863T1 (en) | A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker | |
| EP2579873A4 (en) | Novel prolylcarboxypeptidase inhibitors | |
| HK1203962A1 (en) | Riazinone compound and -type calcium channel inhibitor | |
| EP2762148A4 (en) | Novel phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition | |
| EP2851074A4 (en) | Analgesic pharmaceutical composition | |
| EP2785343A4 (en) | Pharmaceutical composition for preventing or treating hyperlipidemia | |
| ZA201202951B (en) | Pharmaceutical composition containing a phenocarbamate acetylcholinesterase inhibitor |